First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
This summary needs review. Please check the official study record and contact the research team for details.
In Liège
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In LiègeThis study was terminated in the United States. It is testing AMG 579 for schizophrenia.
In GlendaleThis study was terminated in Belgium, in Germany, in Austria, .... It is testing SAFETY AND TOLERABILITY AND TO EXPLORE THE POTENTIAL THERAPEUTIC EFFICACY OF A NOVEL GLUTAMATE MODULATOR for Schizophrenia.
In GermanyThis study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
In CopenhagenThis study is looking at whether Fisher Wallace Cranial Electrotherapy Stimulator Device can help people with depression. Participants take part in Fisher Wallace Cranial Electrotherapy Stimulator Device and complete follow-up assessments.
In New YorkThis study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
In StockholmThis summary needs review. Please check the official study record and contact the research team for details.
In PittsburghThis summary needs review. Please check the official study record and contact the research team for details.
In DurhamThis study is completed. It is testing asenapine for schizophrenia.
Location not clearly listedThis study exists to understand how the medication New holds up over time after the earliest research stage. Researchers are trying to understand what helps the medication New stay useful, realistic, and easier to follow over time.
In BelmontThis study is active but not recruiting in the United States. It is testing DMT for Depression.
In West HavenThis study is completed. It is testing asenapine for Bipolarity.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.